-
STAT News – Biotech3 months agoOpinion: Congress must fix the No Surprises Act before it bankrupts patients and employers
Five years ago, President Trump delivered a historic victory for American patients when he signed the No Surprises Act (NSA) into law. The promise of this...
-
STAT News – Biotech3 months agoOpinion: How OB-GYNs like me are increasingly able to treat pain from IUDs and other gynecologic procedures
In recent years, a growing outcry has drawn long-overdue attention to a difficult truth: girls’ and women’s pain has too often been dismissed and undertreated in...
-
STAT News – Biotech3 months agoSTAT+: Novartis picks up experimental breast cancer therapy for $2B
LONDON — Novartis said Friday it was buying an experimental breast cancer drug from Delaware-based Synnovation Therapeutics for $2 billion upfront. The deal includes includes up...
-
Fierce Biotech3 months ago
Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
Novartis has struck a deal to buy Synnovation Therapeutics’ pan-mutant‑selective PI3Kα inhibitor for $2 billion upfront, securing an asset that could defend its breast cancer franchise...
-
Fierce Biotech3 months ago
Gilead turns down chance to build on Assembly’s phase 1-stage HBV antiviral
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner on other assets.
-
Fierce Biotech3 months ago
Gilead turns down chance to build on Assembly’s phase 1-stage HBV antiviral
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner on other assets.
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Metastasis Slowed by Targeting Lipid Metabolism in Healthy Lung Cells
Lung metastasis remains one of the turning points in cancer progression, in part because the lung provides a uniquely supportive niche for incoming tumor cells. Among...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Modifying T Cell Receptor Improves Targeted Cancer Therapy
Much of the challenge in developing cancer therapies is determining methods to improve the effectiveness of the immune system’s ability to identify and kill cancer cells....
-
GEN – Genetic Engineering & Biotechnology News3 months agoComputational Model Predicts Telomere Length from Images of Routine Histopathology Slides
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a new computational tool, TLPath, that can infer changes occurring at the ends of chromosomes—the telomeres—by...
-
STAT News – Biotech3 months agoSTAT+: Political influence ‘a serious problem’ for FDA under Trump, former commissioner says
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly. At...
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
